Skip to main content
. 2017 Oct 23;8:2031. doi: 10.3389/fmicb.2017.02031

Table 1.

Oxford challenge studies: clinical parameters.

Study Typhoid challenge (N = 23) Paratyphoid challenge (N = 40)
Challenge agent, strain S. enterica serovar Typhi, Quailes strain S. enterica serovar Paratyphi A, strain NVGH308
Participants included in ALS analysis (type) Challenge and diagnosed participants only All challenged participants
Challenge dose level Low High Low Lower
Target dose 1–5 × 103 10–50 × 103 1–5 × 103 0.5–1.0 × 103
Actual dose, median [range] 1.05 × 103 [0.7–1.8] 19.8 × 103 [15.5–27.0] 2.40 × 103 [2.2–2.8] 0.91 × 103 [0.7–1.3]
Number assessed 11 12 20 20
Male sex, N (%) 11 (100) 7 (58) 10 (50) 11 (55)
Median age, yrs [range] 27 [19–41] 28 [20–44] 28 [19–49] 28 [23–50]
Attack rate, N (%) na na 12 (60) 8 (40)
Median time to diagnosis, days [IQR] 11 [7–13] 8 [6–9] 6 [6–7] 8 [8–9]
Mode diagnosis, n(%)
Temperature criterion 6 (60) 7 (58) 1 (9) 0 (0)
Blood culture criterion 4 (40)* 5 (42) 11 (81) 8 (100)
≥1 positive blood cultures, N (% diagnosed) 9 (90)* 10 (83) 12 (100) 8 (100)
Median duration bacteraemia, days [IQR] 1 [1–2] 2 [1–3] 4 [2.5–5] 1 [1–4.5]
Median temperature at diagnosis, °C [IQR] 37.9 [36.7–38.7] 37.8 [37.3–38.1] 37.4 [36.9–38.0] 36.9 [36.5–37.3]
Median heart rate at diagnosis, bpm [IQR] 96 [79–109] 95 [83–104] 87 [80–92] 83 [79–89]
Typhoid symptom triad*, N (%) 11 (55) 12 (75) 6 (30) 3 (15)
*

Typhoid symptom triad = fever, headache plus abdominal pain. na, not applicable.